See more : Surgutneftegas Public Joint Stock Company (SNGS.ME) Income Statement Analysis – Financial Results
Complete financial analysis of 908 Devices Inc. (MASS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of 908 Devices Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Creaspac AB (publ) (CPAC-SPAC.ST) Income Statement Analysis – Financial Results
- Medicare Group Q.P.S.C. (MCGS.QA) Income Statement Analysis – Financial Results
- Magnificent Hotel Investments Limited (0201.HK) Income Statement Analysis – Financial Results
- Svarnim Trade Udyog Limited (SNIM.BO) Income Statement Analysis – Financial Results
- Baota Industry Co., Ltd. (000595.SZ) Income Statement Analysis – Financial Results
908 Devices Inc. (MASS)
About 908 Devices Inc.
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 50.23M | 46.85M | 42.21M | 26.89M | 17.97M | 22.05M |
Cost of Revenue | 24.91M | 20.83M | 18.97M | 11.97M | 9.83M | 9.66M |
Gross Profit | 25.32M | 26.02M | 23.23M | 14.92M | 8.14M | 12.39M |
Gross Profit Ratio | 50.41% | 55.54% | 55.05% | 55.49% | 45.31% | 56.19% |
Research & Development | 21.90M | 17.53M | 13.07M | 8.24M | 8.99M | 9.53M |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 46.18M | 43.88M | 32.24M | 12.50M | 11.29M | 9.30M |
Other Expenses | 0.00 | 1.82M | 386.00K | -6.03M | 301.00K | 50.00K |
Operating Expenses | 68.08M | 61.41M | 45.30M | 20.74M | 20.29M | 18.83M |
Cost & Expenses | 92.99M | 82.23M | 64.28M | 32.71M | 30.12M | 28.49M |
Interest Income | 6.48M | 2.03M | 500.00K | 100.00K | 200.00K | 0.00 |
Interest Expense | 201.00K | 129.00K | 486.00K | 976.00K | 1.53M | 1.15M |
Depreciation & Amortization | 2.38M | 1.61M | 925.00K | 831.00K | 900.00K | 896.00K |
EBITDA | -34.03M | -31.82M | -20.94M | -11.01M | -10.94M | -5.49M |
EBITDA Ratio | -67.74% | -75.52% | -51.37% | -44.04% | -60.89% | -24.91% |
Operating Income | -42.76M | -35.38M | -22.07M | -5.82M | -12.14M | -6.44M |
Operating Income Ratio | -85.13% | -75.52% | -52.29% | -21.62% | -67.57% | -29.20% |
Total Other Income/Expenses | 6.15M | 1.82M | -100.00K | -7.00M | -1.23M | -1.10M |
Income Before Tax | -36.61M | -33.56M | -22.17M | -12.82M | -13.37M | -7.54M |
Income Before Tax Ratio | -72.89% | -71.64% | -52.53% | -47.66% | -74.41% | -34.17% |
Income Tax Expense | -211.00K | -1.82M | -53.00K | -5.88M | 1.83M | 50.00K |
Net Income | -36.40M | -31.74M | -22.12M | -6.94M | -15.20M | -7.54M |
Net Income Ratio | -72.47% | -67.75% | -52.40% | -25.79% | -84.60% | -34.17% |
EPS | -1.13 | -1.01 | -0.79 | -0.25 | -0.58 | -0.40 |
EPS Diluted | -1.13 | -1.01 | -0.79 | -0.25 | -0.58 | -0.40 |
Weighted Avg Shares Out | 32.21M | 31.49M | 27.96M | 27.27M | 26.20M | 18.98M |
Weighted Avg Shares Out (Dil) | 32.24M | 31.49M | 27.96M | 27.27M | 26.20M | 18.98M |
Cathie Wood's ARK Funds Are Loading Up on These 5 Red-Hot Stocks Trading Under $10
908 Devices, Inc. (MASS) Q2 2023 Earnings Call Transcript
908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates
908 Devices Reports Second Quarter 2023 Financial Results and Updates 2023 Revenue Outlook
908 Devices Partners with Tennessee State and Local Agencies in the Fight Against Drug Trafficking Through a New Pilot Program
Cathie Wood's ARK Funds Continue to Buy These 5 Stellar ‘Strong Buy' Stocks Trading Under $10
908 Devices Launches Remote and Continuous Area Monitoring for Aerosol and Vapor Detection
908 Devices to Report Second Quarter Financial Results on August 8, 2023
908 Devices Inc. (MASS) Soars 8.5%: Is Further Upside Left in the Stock?
5 Sizzling ‘Strong Buy' Stocks Under $10, and ARK's Cathie Wood Loves 3 of Them
Source: https://incomestatements.info
Category: Stock Reports